Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 30, 2007 11:10 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity to Present At Acumnet Biofin Rodman & Renshaw Healthcare Conference

CAMBRIDGE, Mass., Oct. 30, 2007 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Steven H. Holtzman,...
October 29, 2007 16:45 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity Announces Advancement of Lead Development Program and Third Quarter Financial Results

CAMBRIDGE, Mass., Oct. 29, 2007 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced results for the third...
October 25, 2007 08:09 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity and MedImmune Present Preliminary Phase 1 Data Demonstrating Biological Activity of IPI-504, A Novel Hsp90 Inhibitor, in Advanced Non-Small Cell Lung Cancer

Evidence of Disease Stabilization and PET Responses Reported from Phase 1 Clinical Trial; Phase 2 Enrollment Scheduled to Begin by Year-End Preclinical Evidence of Activity of...
October 23, 2007 09:17 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity and MedImmune Announce Issuance of U.S. Patent for Proprietary Heat Shock Protein 90 Inhibitors

CAMBRIDGE, Mass. and GAITHERSBURG, Md., Oct. 23, 2007 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) and MedImmune, Inc. today announced that the United States Patent and Trademark...
October 23, 2007 08:00 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity Announces Conference Call Discussing Third Quarter 2007 Results

CAMBRIDGE, Mass., Oct. 23, 2007 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Infinity management...
October 03, 2007 09:08 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity to Present at 2007 Bio Investor Forum

CAMBRIDGE, Mass., Oct. 3, 2007 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Steven H. Holtzman,...
September 19, 2007 08:46 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity to Present At UBS Global Life Sciences Conference

CAMBRIDGE, Mass., Sept. 19, 2007 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Jeffrey K. Tong,...
September 17, 2007 09:00 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity and MedImmune Receive Orphan Drug Designation for IPI-504 for Treatment of Gastroinstestinal Stromal Tumors

CAMBRIDGE, Mass. and GAITHERSBURG, Md., Sept. 17, 2007 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) and MedImmune today announced that the U.S. Food and Drug Administration's (FDA)...
August 01, 2007 16:34 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity Announces Second Quarter Results and Highlights Recent Accomplishments

CAMBRIDGE, Mass., Aug. 1, 2007 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced results for the second...
July 26, 2007 16:33 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity Announces Conference Call Discussing Second Quarter 2007 Results

CAMBRIDGE, Mass., July 26, 2007 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Infinity management...